Total Payments
$37,917
2024 Payments
$125.00
Companies
11
Transactions
104
Medicare Patients
515
Medicare Billing
$55,244
Payment Breakdown by Category
Consulting$22,735 (60.0%)
Travel$5,417 (14.3%)
Other$4,031 (10.6%)
Research$3,334 (8.8%)
Food & Beverage$2,400 (6.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $22,735 | 8 | 60.0% |
| Travel and Lodging | $5,417 | 18 | 14.3% |
| Grant | $4,000 | 2 | 10.5% |
| Unspecified | $3,334 | 9 | 8.8% |
| Food and Beverage | $2,400 | 66 | 6.3% |
| Honoraria | $31.40 | 1 | 0.1% |
Payments by Type
General
$34,583
95 transactions
Research
$3,334
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $14,840 | 11 | $0 (2020) |
| Corcept Therapeutics | $9,706 | 27 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $5,025 | 2 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $4,694 | 4 | $0 (2017) |
| PFIZER INC. | $2,650 | 25 | $0 (2022) |
| Allergan Inc. | $498.11 | 16 | $0 (2018) |
| Shire North American Group Inc | $182.04 | 5 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $155.63 | 5 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $63.39 | 5 | $0 (2019) |
| Ipsen Biopharmaceuticals, Inc | $59.15 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125.00 | 1 | Corcept Therapeutics ($125.00) |
| 2023 | $43.35 | 1 | Xeris Pharmaceuticals, Inc. ($43.35) |
| 2022 | $55.00 | 1 | PFIZER INC. ($55.00) |
| 2020 | $3,235 | 2 | Novartis Pharmaceuticals Corporation ($1,875) |
| 2019 | $22,306 | 32 | Novo Nordisk Inc ($13,480) |
| 2018 | $4,752 | 31 | Corcept Therapeutics ($4,009) |
| 2017 | $7,401 | 36 | SANOFI-AVENTIS U.S. LLC ($4,694) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Endocrinology | ||||||
| 04/26/2023 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $43.35 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 06/12/2022 | PFIZER INC. | GENOTROPIN (Drug) | Food and Beverage | In-kind items and services | $55.00 | General |
| Category: ENDOCRINE DISEASE | ||||||
| 03/20/2020 | Novartis Pharmaceuticals Corporation | SIGNIFOR (Drug) | — | In-kind items and services | $1,875.00 | Research |
| Study: RESEARCH RELATED PUBLICATIONS SUPPORT • Category: ONCOLOGY | ||||||
| 01/21/2020 | Novo Nordisk Inc | Norditropin (Biological) | Consulting Fee | Cash or cash equivalent | $1,360.00 | General |
| Category: Growth Hormone | ||||||
| 12/06/2019 | Novo Nordisk Inc | Norditropin (Drug) | Consulting Fee | Cash or cash equivalent | $5,015.00 | General |
| Category: Growth Hormone | ||||||
| 12/06/2019 | Novo Nordisk Inc | Norditropin (Drug) | Travel and Lodging | In-kind items and services | $403.60 | General |
| Category: Growth Hormone | ||||||
| 12/06/2019 | Novo Nordisk Inc | Norditropin (Drug) | Travel and Lodging | In-kind items and services | $225.00 | General |
| Category: Growth Hormone | ||||||
| 12/06/2019 | Novo Nordisk Inc | Norditropin (Drug) | Travel and Lodging | In-kind items and services | $180.36 | General |
| Category: Growth Hormone | ||||||
| 12/05/2019 | Novo Nordisk Inc | Norditropin (Drug) | Consulting Fee | Cash or cash equivalent | $1,360.00 | General |
| Category: Growth Hormone | ||||||
| 10/17/2019 | Novo Nordisk Inc | Norditropin (Drug) | Consulting Fee | Cash or cash equivalent | $4,675.00 | General |
| Category: Growth Hormone | ||||||
| 10/17/2019 | Novo Nordisk Inc | Norditropin (Drug) | Travel and Lodging | In-kind items and services | $626.81 | General |
| Category: Growth Hormone | ||||||
| 10/17/2019 | Novo Nordisk Inc | Norditropin (Drug) | Travel and Lodging | In-kind items and services | $228.29 | General |
| Category: Growth Hormone | ||||||
| 10/17/2019 | Novo Nordisk Inc | Norditropin (Drug) | Travel and Lodging | In-kind items and services | $206.33 | General |
| Category: Growth Hormone | ||||||
| 09/04/2019 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $91.50 | General |
| Category: Endocrinology | ||||||
| 06/15/2019 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $559.29 | General |
| 05/30/2019 | Novartis Pharmaceuticals Corporation | SIGNIFOR (Drug) | Consulting Fee | Cash or cash equivalent | $3,150.00 | General |
| Category: ONCOLOGY | ||||||
| 05/18/2019 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | In-kind items and services | $134.47 | General |
| Category: Endocrinology | ||||||
| 05/18/2019 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $37.17 | General |
| Category: Endocrinology | ||||||
| 05/18/2019 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: Endocrinology | ||||||
| 05/18/2019 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Endocrinology | ||||||
| 05/17/2019 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | In-kind items and services | $502.60 | General |
| Category: Endocrinology | ||||||
| 05/17/2019 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $69.67 | General |
| Category: Endocrinology | ||||||
| 05/16/2019 | Corcept Therapeutics | Korlym (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Endocrinology | ||||||
| 04/24/2019 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $109.31 | General |
| Category: Endocrinology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATIONS SUPPORT | Novartis Pharmaceuticals Corporation | $1,875 | 1 |
| Study 455 | Corcept Therapeutics | $1,459 | 8 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 117 | 131 | $66,228 | $13,059 |
| 2022 | 6 | 123 | 132 | $69,126 | $13,122 |
| 2021 | 7 | 205 | 221 | $33,243 | $20,956 |
| 2020 | 3 | 70 | 103 | $24,962 | $8,107 |
Total Patients
515
Total Services
587
Medicare Billing
$55,244
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 60 | $27,000 | $5,529 | 20.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $15,147 | $2,899 | 19.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $13,433 | $2,406 | 17.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 19 | $5,624 | $1,201 | 21.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 16 | $5,024 | $1,025 | 20.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 26 | 26 | $23,166 | $4,061 | 17.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 40 | $18,000 | $3,542 | 19.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $14,140 | $2,629 | 18.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 13 | $7,852 | $1,839 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 14 | $4,144 | $725.25 | 17.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 19 | 19 | $1,824 | $325.36 | 17.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 43 | 43 | $11,595 | $6,828 | 58.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 39 | 39 | $7,132 | $5,021 | 70.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 33 | 39 | $5,379 | $3,853 | 71.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 21 | $4,651 | $2,635 | 56.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 20 | $1,927 | $1,058 | 54.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 13 | $1,392 | $838.43 | 60.2% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 46 | 46 | $1,168 | $722.40 | 61.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 18 | 46 | $9,522 | $2,809 | 29.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 23 | 23 | $6,240 | $2,750 | 44.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 29 | 34 | $9,200 | $2,548 | 27.7% |
About Dr. Susan Samson, M.D
Dr. Susan Samson, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790899227.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Susan Samson, M.D has received a total of $37,917 in payments from pharmaceutical and medical device companies, with $125.00 received in 2024. These payments were reported across 104 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($22,735).
As a Medicare-enrolled provider, Samson has provided services to 515 Medicare beneficiaries, totaling 587 services with total Medicare billing of $55,244. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location Jacksonville, FL
- Active Since 08/19/2006
- Last Updated 11/27/2020
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1790899227
Products in Payments
- Norditropin (Drug) $12,920
- Korlym (Drug) $8,247
- SIGNIFOR (Drug) $5,025
- NO PRODUCT DISCUSSED (Drug) $4,694
- SOMAVERT (Drug) $2,420
- Norditropin (Biological) $1,360
- LINZESS (Drug) $374.95
- NATPARA (Drug) $165.26
- GENOTROPIN (Drug) $158.75
- VIBERZI (Drug) $115.25
- Somatuline Depot 120mg-.5ml (Drug) $59.15
- RECORLEV (Drug) $43.35
- JARDIANCE (Drug) $35.01
- TRADJENTA (Drug) $28.38
- JANUVIA (Drug) $26.15
- NATPARA (PARATHYROID HORMONE) (Drug) $16.78
- ZENPEP (Drug) $7.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Jacksonville
Dr. Mae Sheikh-Ali, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.2M
Endocrinology, Diabetes & Metabolism $1.2M
Dr. Wasim Deeb, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $373,299
Endocrinology, Diabetes & Metabolism $373,299
Dr. Senan Sultan, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $199,408
Endocrinology, Diabetes & Metabolism $199,408
Dr. Ricardo Silva, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $65,145
Endocrinology, Diabetes & Metabolism $65,145
Dr. Melissa Morgan, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $34,294
Endocrinology, Diabetes & Metabolism $34,294
Dr. Firas Warda, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $24,766
Endocrinology, Diabetes & Metabolism $24,766